Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Diffuse Large B Cell Lymphoma Patients Treated with RCHOP

Faculty Medicine Year: 2024
Type of Publication: ZU Hosted Pages:
Authors:
Journal: ZUMJ Zagazig University Volume:
Keywords : Impact , Prognostic Nutritional Index , Systemic Immune-Inflammation    
Abstract:
Background: The most frequent lymphoma in Egyptian adults is diffuse large B-cell lymphoma (DLBCL). Patients with DLBCL experienced a wide variety of prognoses. It has become challenging to identify high-risk groups using IPI alone because the outcome of DLBCL patients has improved with the introduction of rituximab. It would thus be important to find prognostic indicators for predicting patient subgroups with poor prognosis and choose the efficient therapy regimen in accordance. One of the factors thought to contribute to the formation of cancer metastases and cancer progression is inflammation. The systemic immune inflammation index (SII) is a reliable indicator of cancer patients' prognosis. It seems that nutritional status affects how different solid tumors behave. To evaluate the immunological nutritional condition of cancer patients, the Prognostic Nutritional Index (PNI) was developed. The goal of our research was to assess SII and PNI's prognostic and predictive significance in DLBCL patients receiving RCHOP therapy. Method: This prospective, non-randomized study aimed to evaluate the prognostic value of SII and PNI in patients DLBCL receiving RCHOP. Eightyfour patients were included. Results: The optimal cut-off values for PNI and SII using the ROC curve were 50 and 410, respectively. PNI and SII were significantly associated with a complete remission rate. Multivariate analyses showed that low PNI and high SII were independent predictors of poor relapse-free and overall survival. Conclusions: A growing body of evidence demonstrates the value of pretreatment PNI and SII as simple prognostic indicators in DLBCL patients receiving RCHOP.
   
     
 
       

Author Related Publications

  • Marwa Mohamed Ibrahim Atya, "Peripheral blood expression of matrix metalloproteinases-2,-9 and tissue inhibitor of matrix metalloprotinases-2 as molecular markers for diagnosis and staging of bladder cancer in Egypt", IJAR, 2015 More
  • Marwa Mohamed Ibrahim Atya, "Microrna-150 and Microrna-101 As Diagnostic Markers for Hepatitis B Virus Related Hepatocellular Carcinoma in Egypt", SciTechnol, 2017 More
  • Marwa Mohamed Ibrahim Atya, "piRABC and TNFSF4 as biomarkers for diagnosis and staging of bladder cancer.", Zagazig University, 2024 More
  • Marwa Mohamed Ibrahim Atya, "Infection index: a promising additive tool in detecting bacterial colonization", Wolters Kluwer - Medknow, 2021 More
  • Marwa Mohamed Ibrahim Atya, "VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory", BMJ group, 2024 More

Department Related Publications

  • Rania Ahmed Khalil Ghonem, "The Rate of Extended-Spectrum B-Lactamases among Commonly Isolated Enterobacteriaceae in Cancer Patients in Zagazig University Hospitals", Scientific & Academic Publishing. All Rights Reserved, 2017 More
  • Rania Ahmed Khalil Ghonem, "Study of Minimal Residual Disease in Adults with B-Lineage Acute Lymphoblastic Leukemia by Flowcytometry", Journal of Cancer Therapy,, 2017 More
  • Amal Ahmed Ali Zedan, "Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma", Endemic and Tropical Medicine Department . Zagazig University, 2018 More
  • Amany Mohamed Mohyldeen, "Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet’s disease: which and when to use?", International League of Associations for Rheumatology, 2018 More
  • Amany Mohamed Mohyldeen, "Vitamin D Status in Hemophilia Patients Attending at Zagazig Universty Children Hospitals", Faculty of Medicine-Zagazig Universi, 2020 More
Tweet